Gubra A/S provided revenue guidance for the year 2023. for the year, the company expects Organic revenue growth 10% vs. 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
349 DKK | +7.06% | +6.08% | +179.20% |
05-07 | Gubra A/S Announces Management Changes | CI |
04-17 | Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss | CI |
1st Jan change | Capi. | |
---|---|---|
+179.20% | 774M | |
+19.33% | 125B | |
+13.95% | 109B | |
-3.53% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.62% | 16.64B | |
+0.99% | 13.45B | |
+21.79% | 11.32B |
- Stock Market
- Equities
- GUBRA Stock
- News Gubra A/S
- Gubra A/S Provides Revenue Guidance for the Year 2023